Phase 2 study for people with Stroke

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor ThromBio Pty. Ltd.
Registry number NCT06813651
Started 4 October 2025 Today 16 October 2026 Estimated completion 30 December 2026

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
John Hunter Hospital Newcastle NSW Recruiting
Royal North Shore Hospital St Leonards NSW Not yet recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 78

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

1. Patient aged 18 years or more

2. Patient has an AIS due to tandem occlusion, including large vessel occlusion (LVO) within the intra-cranial anterior circulation and presumed atherosclerotic occlusion of the cervical internal carotid artery origin

3. CT perfusion indicates the presence of salvageable brain tissue, defined as ischaemic core \<70mL with a mismatch ratio \>1.8 and absolute mismatch \>15mL.

4. Patient has at least a mild grade of neurological impairment (NIHSS \>4)

5. Patient has an estimated pre-stroke mRS of less than 4

Exclusion Criteria:

1. Patient is considered unlikely to benefit from study intervention defined by one of the following:

1. Advanced dementia

2. Severe pre-stroke disability (mRS score 4-5)

3. Glasgow Coma Score (GCS) 3 to 5

4. Evidence of a large well-defined ischaemic lesion measuring more than one third of the middle cerebral artery (MCA) territory

2. Uncontrolled hypertension (SBP \>180 or DBP \>110, refractory to medical therapy)

3. Intracranial haemorrhage within the last 90 days

4. Myocardial infarction or stroke within the last 30 days

5. Patient has an underlying disease process with a life expectancy of \<90 days

6. Known treatment with anticoagulants

7. Known severe liver disease

8. Known bleeding disorder

9. Cardiopulmonary resuscitation or arterial puncture at non-compressible site or lumbar puncture within 7 days

10. Another medical illness or social circumstance that may interfere with outcome assessments and follow-up

11. Known or suspected pregnancy

12. Patients currently participating in another interventional clinical trial

13. Informed consent unable to be obtained from the patient or their Person Responsible/Medical Treatment Decision Maker prior to study interventions

Dates on the record

Started 4 October 2025
Estimated completion 30 December 2026
Registry last updated 25 November 2025
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 25 November 2025.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.